The melanocortin system and insulin resistance in humans: Insights from a patient with complete POMC deficiency and type 1 diabetes mellitus

International Journal of Obesity

Volumn 38, Issue 1, 2014, Pages 148-151

  Aslan, I R ^a   Ranadive, S A ^b   Valle, I ^c   Kollipara, S ^d   Noble, J A ^a   Vaisse, C ^c  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Keiser Permanente   (United States)

Author keywords

insulin resistance; melanocortin system; POMC mutation; type 1 diabetes mellitus

Indexed keywords

MELANOCORTIN; PROOPIOMELANOCORTIN;

5' UNTRANSLATED REGION; ARTICLE; CASE REPORT; GLUCOSE HOMEOSTASIS; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; PRIORITY JOURNAL; PROOPIOMELANOCORTIN DEFICIENCY; PROTEIN SYNTHESIS; PUBERTY;

RODENTIA;

ADRENAL INSUFFICIENCY; CHILD; DIABETES MELLITUS, TYPE 1; ENERGY METABOLISM; FEEDING BEHAVIOR; GENOTYPE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MELANOCORTINS; OBESITY; PEDIATRIC OBESITY; PRO-OPIOMELANOCORTIN; SEQUENCE ANALYSIS, DNA; WEIGHT GAIN;

EID: 84891833262     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.53     Document Type: Article

References (16)

1. Farooqi S, O'Rahilly S. Genetics of obesity in humans. Endocr Rev 2006; 27: 710-718.
2. Coll AP, Challis BG, Lopez M, Piper S, Yeo GS, O'Rahilly S. Proopiomelanocortindeficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 2005; 54: 2269-2276.
3. Coll AP, Loraine Y, C Tung. Pro-opiomelanocortin (POMC)-derived peptides and the regulation of energy homeostasis. Mol Cell Endocrinol 2009; 300: 147-151.
4. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 155-157.
5. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003; 88: 4633-4640.
6. Farooqi IS, Drop S, Clements A, Keogh JM, Biernacka J, Lowenbein S et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006; 55: 2549-2553.
7. Clement K, Dubern B, Mencarelli M, Czernichow P, Ito S, Wakamatsu K et al. Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J Clin Endocrinol Metab 2008; 93: 4955-4962.
8. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57: 1084-1092.
9. Kaufman FR. Type 1 diabetes mellitus. Pediatr Rev. 2003; 24: 291-300.
10. Coppari R, Bjorbaek C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 2012; 11: 692-708.
11. Xu Y, Elmquist JK, Fukuda M. Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann N Y Acad Sci 2011; 1243: 1-14.
12. Morton GJ, Schwartz MW. Leptin and the central nervous system control of glucose metabolism. Physiol Rev 2011; 91: 389-411.
13. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007; 449: 228-232.
14. Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86: 3448.
15. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401.
16. Lubrano-Berthelier C, Le Stunff C, Bougneres P, Vaisse C. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. J Clin Endocrinol Metab 2004; 89: 2028-2032.